June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
A novel KCNV2 variant in Cone Dystrophy with Supernormal Rod Response (CDSRR) – Evidence for Pathogenicity
Author Affiliations & Notes
  • Paul F Kenna
    Research Foundation, Royal Victoria Eye and Ear Hospital Dublin, Ireland
    Department of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Emma Duignan
    Department of Ophthalmology, Royal Victoria Eye and Ear Hospital Dublin, Ireland
  • Laura Whelan
    Department of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Ciara Shortall
    Department of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • G.Jane Farrar
    Department of Genetics, The University of Dublin Trinity College, Dublin, Ireland
  • Footnotes
    Commercial Relationships   Paul Kenna None; Emma Duignan None; Laura Whelan None; Ciara Shortall None; G.Jane Farrar None
  • Footnotes
    Support  Research Foundation, The Royal Victoria Eye and Ear Hospital Dublin; Health Research Charities Ireland/Fighting Blindness Ireland/Health Research Board (MRCG-2016-14; 2020-007); Fighting Blindness Ireland (FB18CRE and FB20DOC); Health Research Board, Ireland (HRA_POR_2010_97); Science Foundation Ireland (16/IA/4452)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 490 – A0067. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paul F Kenna, Emma Duignan, Laura Whelan, Ciara Shortall, G.Jane Farrar; A novel KCNV2 variant in Cone Dystrophy with Supernormal Rod Response (CDSRR) – Evidence for Pathogenicity. Invest. Ophthalmol. Vis. Sci. 2022;63(7):490 – A0067.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To describe the phenotypic and genotypic findings in two siblings with a severe cone dystrophy and electroretinogram (ERG) findings characteristic of CDSRR.

Methods : Over 1600 genetic retinopathy patients attending the Genetic Eye Disease Service at the Royal Victoria Eye and Ear Hospital, Dublin, have been recruited prospectively as part of Target 5000. Testing includes: best-corrected visual acuity (BCVA), Goldmann perimetry, Lanthony D15 colour vision, slit-lamp biomicroscopy, ISCEV clinical standard electrodiagnostics, colour and autofluorescence fundus photography and optical coherence tomography. DNA samples undergo exon sequencing of c. 254 candidate genes using target-capture oligo panels or whole exome sequencing in research and/or accredited facilities. Variants of uncertain significance are subjected to in silico analysis.

Results : Two brothers, 15 and 16 years old respectively, reported life-long reduced vision and photophobia. BCVA was 6/48 and each had red/green colour deficits. ERGs showed delayed rod-isolated responses of low-normal amplitudes and dark-adapted rod-dominated maximal responses of unusually high amplitude. Cone-isolated responses were delayed and markedly reduced in amplitudes. This constellation suggested CDSRR as a likely diagnosis. Genotyping revealed compound heterozygosity for KCNV2 c.1381G>A, p.(Gly461Arg), a known pathogenic variant, and c.1354G>C, p.(Ala452Pro), a previously unreported variant. In silico analyses using SIFT, Mutation Taster and Polyphen 2 predicted the latter to be deleterious.

Conclusions : KCNV2 (OMIM *607604), causative of CDSRR, encodes the subunit Kv8.2 of a voltage-gated potassium channel in rods and cones. Activation is enabled by complex formation with other subunits and expression influenced by transcription factors CRX and NRL. KCNV2 variants underlie up to 4.3% of cone dystrophies. c.1381G>A, p.(Gly461Arg) is the most commonly reported variant. c.1354G>C, p.(Ala452Pro), a previously unreported missense variant, is absent from the gnomAD database and has not been reported in ClinVAR or HGMD. It affects a highly conserved amino acid in the ion transport domain. Two missense variants affecting a nearby codon have been reported to cause CDSRR. Further functional studies are underway, however, this report provides, to the best of our knowledge, the first evidence for pathogenicity of KCNV2 c.1354G>C, p.(Ala452Pro).

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×